NL184467B - 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten. - Google Patents

6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.

Info

Publication number
NL184467B
NL184467B NLAANVRAGE7809368,A NL7809368A NL184467B NL 184467 B NL184467 B NL 184467B NL 7809368 A NL7809368 A NL 7809368A NL 184467 B NL184467 B NL 184467B
Authority
NL
Netherlands
Prior art keywords
prostaglandin
oxo
derivatives
preparation
pharmaceutical preparations
Prior art date
Application number
NLAANVRAGE7809368,A
Other languages
English (en)
Other versions
NL184467C (nl
NL7809368A (nl
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NL7809368A publication Critical patent/NL7809368A/nl
Publication of NL184467B publication Critical patent/NL184467B/nl
Application granted granted Critical
Publication of NL184467C publication Critical patent/NL184467C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NLAANVRAGE7809368,A 1977-09-16 1978-09-14 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten. NL184467C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52110504A JPS6022710B2 (ja) 1977-09-16 1977-09-16 プロスタグランジン類似化合物

Publications (3)

Publication Number Publication Date
NL7809368A NL7809368A (nl) 1979-03-20
NL184467B true NL184467B (nl) 1989-03-01
NL184467C NL184467C (nl) 1989-08-01

Family

ID=14537436

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7809368,A NL184467C (nl) 1977-09-16 1978-09-14 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL8203068A NL8203068A (nl) 1977-09-16 1982-08-02 Prostaglandinederivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL8203068A NL8203068A (nl) 1977-09-16 1982-08-02 Prostaglandinederivaten.

Country Status (19)

Country Link
US (2) US4215142A (nl)
JP (1) JPS6022710B2 (nl)
AU (1) AU527940B2 (nl)
BE (1) BE870531A (nl)
CA (1) CA1119169A (nl)
CH (2) CH638492A5 (nl)
DE (2) DE2840032C2 (nl)
DK (3) DK405078A (nl)
FR (2) FR2403333A1 (nl)
GB (2) GB2079268B (nl)
HK (1) HK82185A (nl)
HU (1) HU182553B (nl)
IE (1) IE47439B1 (nl)
IT (2) IT1192580B (nl)
LU (1) LU80235A1 (nl)
MY (1) MY8600652A (nl)
NL (2) NL184467C (nl)
SG (1) SG58485G (nl)
ZA (1) ZA785230B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2834248A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe
DE2913856A1 (de) * 1979-04-06 1980-10-23 Hoechst Ag Neue prostaglandinderivate in der 6-keto-pge tief 1 -reihe
DE3270976D1 (en) * 1981-06-29 1986-06-12 Ono Pharmaceutical Co Prostaglandin analogues
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS59163365A (ja) * 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JPS60181068A (ja) * 1984-02-29 1985-09-14 Teijin Ltd ６−置換プロスタグランジンｅ↓１類およびその製造法
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
DE3704825A1 (de) * 1987-02-16 1988-08-25 Froelich Juergen Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DE3708537A1 (de) * 1987-03-13 1988-09-22 Schering Ag 6-oxoprostaglandin-e-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPS63202544U (nl) * 1987-06-22 1988-12-27
US5078195A (en) * 1989-01-10 1992-01-07 Schoen Siegfried J Double-walled pleated curtain
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
WO2001046134A1 (en) * 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
WO2011072383A1 (en) * 2009-12-18 2011-06-23 Apotex Pharmachem Inc. Processes for the purification of lubiprostone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034003A (en) * 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
US4171447A (en) * 1976-12-30 1979-10-16 The Upjohn Company Tri-halo prostaglandin intermediates
US4124601A (en) * 1976-12-30 1978-11-07 The Upjohn Company Certain 5-halo-6,9α-epoxy-14-bromo(or chloro)-PGF1 compounds

Also Published As

Publication number Publication date
GB2079268A (en) 1982-01-20
IT1213051B (it) 1989-12-07
FR2453851B1 (fr) 1985-10-25
IT1192580B (it) 1988-04-20
DE2858094C2 (de) 1986-03-06
DK620289D0 (da) 1989-12-08
US4278688A (en) 1981-07-14
FR2453851A1 (fr) 1980-11-07
FR2403333A1 (fr) 1979-04-13
IT7827773A0 (it) 1978-09-15
BE870531A (fr) 1979-03-15
GB2006753B (en) 1982-08-04
IE47439B1 (en) 1984-03-21
HK82185A (en) 1985-11-01
IT8619809A0 (it) 1986-03-19
DK620189D0 (da) 1989-12-08
GB2079268B (en) 1982-08-11
HU182553B (en) 1984-02-28
DK620289A (da) 1989-12-08
NL8203068A (nl) 1982-12-01
DK620189A (da) 1989-12-08
ZA785230B (en) 1979-08-29
CA1119169A (en) 1982-03-02
MY8600652A (en) 1986-12-31
NL184467C (nl) 1989-08-01
JPS6022710B2 (ja) 1985-06-03
CH635318A5 (fr) 1983-03-31
DE2840032A1 (de) 1979-03-29
IE781857L (en) 1979-03-16
FR2403333B1 (nl) 1982-05-07
SG58485G (en) 1986-08-01
US4215142A (en) 1980-07-29
NL7809368A (nl) 1979-03-20
DE2840032C2 (de) 1983-12-22
JPS5444639A (en) 1979-04-09
AU3988678A (en) 1980-03-20
CH638492A5 (fr) 1983-09-30
LU80235A1 (fr) 1979-06-01
DK405078A (da) 1979-03-17
GB2006753A (en) 1979-05-10
AU527940B2 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
NL191738C (nl) ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten.
NL7800363A (nl) Nieuwe 4.9-dieen-11b-gesubstitueerde steroid- derivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze steroid- derivaten bevatten.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL7810562A (nl) Ureumderivaten, werkwijze ter bereiding ervan alsmede farmaceutische preparaten.
NL7803626A (nl) 2-alkyleenaminodihydropyridinen, werkwijzen ter berei- ding ervan, alsmede farmaceutische preparaten.
NL7810865A (nl) 6,7-dialkoxy-4-piperidinochinazolinen, farmaceutische preparaten die ze bevatten, en werkwijzen voor de be- reiding daarvan.
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL7804345A (nl) Imidazoazinen en imidazodiazinen, werkwijze ter berei- ding daarvan en farmaceutische preparaten.
NL7811220A (nl) Cefalosporanzuurderivaten, werkwijzen voor de bereiding daarvan, farmaceutische preparaten.
NL7714066A (nl) 1.4-dihydropyridineverbindingen, werkwijze voor de bereiding daarvan en farmaceutische prepara- ten, die deze verbindingen bevatten.
NL930078I2 (nl) Aminederivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze bevatten.
NL7806380A (nl) Pyrazolyl-pyridazinederivaten, werkwijze voor de berei- ding hiervan alsmede de therapeutische toepassing.
NL930126I2 (nl) Dihydropyridine derivaten, werkwijze voor hun bereiding en farmaceutische preparaten die ze bevatten.
NL7802892A (nl) Pseudotrisacchariden, werkwijzen ter bereiding ervan en farmaceutische preparaten.
NL7802069A (nl) Pyrrolidinederivaten, werkwijze voor de berei- ding daarvan en dergelijke pyrrolidinederivaten bevattende geneesmiddelen.
NL187485C (nl) Prostaglandinederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7811292A (nl) Pyridoxol-derivaat, werkwijze voor de bereiding daarvan en farmaceutische preparaten die het bevatten.
NL7802826A (nl) Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
NL7802380A (nl) Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten.
NL184160C (nl) Tegen schimmels werkzame imidazool-derivaten, preparaten die ze bevatten en werkwijze voor de bereiding daarvan.
NL7805038A (nl) 1-acyl-2-hydroxy-1.3-diaminopropaanverbindingen, werk- wijze voor de bereiding daarvan en geneesmiddelen.
NL7807572A (nl) Pyrazolylpyridazinederivaten, werkwijze voor de berei- ding hiervan en de toepassing als geneesmiddel.
NL7808440A (nl) Anti-inflammatoire 1-fenylethanolamine-derivaten, far- maceutische preparaten, die deze verbindingen bevatten en werkwijzen ter bereiding daarvan.
NL7714628A (nl) Gedisubstitueerde piperazinen, werkwijze voor de bereiding daarvan en dergelijke piperazinen bevattende geneesmiddelen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960401